Treatment of relapsed classical Hodgkin lymphoma in the Brentuximab vedoitn era.

Reviewers

Author

• Emad A Abdelhady

Department of Internal Medicine, Clinical Hematology and Bone Marrow Transplantation Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Main Subjects

• Hodgkin’s lymphomas.
• Lymphoproliferative disorders